// Definition
Research being organized at UBC using measurable inflammatory biomarkers (stool and serum markers) to document the anti-inflammatory effects of cannabis in a pediatric Crohn's/Colitis patient using 1:1 THC:CBD oral extract, providing objective clinical evidence beyond patient self-reporting.
// From the Episode
Dr. Natasha describes a case study similar to Colton Turner's but with measurable biomarkers. The stool marker (calprotectin) correlates with intestinal inflammation - as it decreases, inflammation is demonstrably reducing. She also mentions access to 40,000+ patient files from a Canadian medical cannabis clinic for broader research, working with a pain specialist interested in harm reduction (reducing polypharmacy).
// Source
Ep. 130 Hash Church CXXVII 127 →